Cargando…
TRIM59, a novel multiple cancer biomarker for immunohistochemical detection of tumorigenesis
OBJECTIVES AND DESIGN: We identified a novel TRIM59 gene, as an early signal transducer in two (SV40Tag and Ras) oncogene pathways in murine prostate cancer (CaP) models. We explore its clinical applications as a multitumour marker detecting early tumorigenesis by immunohistochemistry (IHC). SETTING...
Autores principales: | Khatamianfar, Vida, Valiyeva, Fatma, Rennie, Paul S, Lu, Wei-yang, Yang, Burton B, Bauman, Glenn S, Moussa, Madeleine, Xuan, Jim W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488719/ https://www.ncbi.nlm.nih.gov/pubmed/23048060 http://dx.doi.org/10.1136/bmjopen-2012-001410 |
Ejemplares similares
-
Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma
por: McCormick Matthews, L H, et al.
Publicado: (2015) -
TRIM59: A potential diagnostic and prognostic biomarker in human tumors
por: Jin, Zheng, et al.
Publicado: (2021) -
Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer—what has gone wrong? A blueprint for the way forward in biomarker studies
por: Huber, F, et al.
Publicado: (2015) -
TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC
por: Lou, Ming, et al.
Publicado: (2020) -
Immunohistochemical categorisation of ductal carcinoma in situ of the breast
por: Meijnen, P, et al.
Publicado: (2008)